Page last updated: 2024-09-03

reboxetine and enkephalin, d-penicillamine (2,5)-

reboxetine has been researched along with enkephalin, d-penicillamine (2,5)- in 1 studies

Compound Research Comparison

Studies
(reboxetine)
Trials
(reboxetine)
Recent Studies (post-2010)
(reboxetine)
Studies
(enkephalin, d-penicillamine (2,5)-)
Trials
(enkephalin, d-penicillamine (2,5)-)
Recent Studies (post-2010) (enkephalin, d-penicillamine (2,5)-)
6261931841,314073

Protein Interaction Comparison

ProteinTaxonomyreboxetine (IC50)enkephalin, d-penicillamine (2,5)- (IC50)
Mu-type opioid receptorHomo sapiens (human)0.0016
Delta-type opioid receptorHomo sapiens (human)0.0011

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carpentier, C; Costentin, J; Leroux-Nicollet, I; Naudon, L; Vilpoux, C1

Other Studies

1 other study(ies) available for reboxetine and enkephalin, d-penicillamine (2,5)-

ArticleYear
Differential effects of chronic antidepressant treatments on micro- and delta-opioid receptors in rat brain.
    European journal of pharmacology, 2002, May-17, Volume: 443, Issue:1-3

    Topics: Animals; Antidepressive Agents; Autoradiography; Binding Sites; Brain; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Injections, Intraperitoneal; Male; Moclobemide; Morpholines; Paroxetine; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Opioid, delta; Receptors, Opioid, mu; Time Factors

2002